XML 47 R30.htm IDEA: XBRL DOCUMENT v3.25.0.1
Financial Instruments (Tables)
12 Months Ended
Dec. 31, 2024
Fair Value Disclosures [Abstract]  
Schedule of Financial Instruments Measured at Fair Value
A summary of financial instruments measured at fair value was as follows (in thousands):
December 31, 2024Level 1Level 2Level 3Total
Cash equivalents:
Money market funds$18,182 $— $— $18,182 
Certificates of deposit5,069 — — 5,069 
Endospan Loans— — 9,535 9,535 
Total assets$23,251 $ $9,535 $32,786 
Long-term liabilities:
Contingent consideration$— $— $52,880 $52,880 
Total liabilities $ $ $52,880 $52,880 
December 31, 2023Level 1Level 2Level 3Total
Cash equivalents:
Money market funds$22,802 $— $— $22,802 
Certificates of deposit3,968 — — 3,968 
Total assets$26,770 $ $ $26,770 
Long-term liabilities:
Contingent consideration$— $— $63,890 $63,890 
Total liabilities$ $ $63,890 $63,890 
Schedule of Reconciliation Of Changes In Fair Value Of Level 3 Liabilities Changes in fair value of Level 3 assets and liabilities are listed in the tables below (in thousands):
Endospan Loans
Balance as of December 31, 2023$— 
Initial value of Additional Endospan Loan8,912 
Change in valuation of Endospan Loans623 
Balance as of December 31, 2024$9,535 
Contingent Consideration
Balance as of December 31, 2023$63,890 
Change in valuation(11,010)
Balance as of December 31, 2024$52,880